Treatment outcome of clonal cytopenias of undetermined significance: a single-institution retrospective study
暂无分享,去创建一个
A. Tefferi | M. Patnaik | P. Nguyen | M. Litzow | M. Shah | D. Jevremovic | A. Al-Kali | N. Gangat | D. Viswanatha | H. Alkhateeb | R. He | Zhuoer Xie | P. Greipp | M. Salama | Antoine N. Saliba | Ahmad Nanaa
[1] P. Campbell,et al. SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS , 2020, Blood.
[2] P. Campbell,et al. SF3B1-mutant myelodysplastic syndrome as a distinct disease subtype - A Proposal of the International Working Group for the Prognosis of Myelodysplastic Syndromes (IWG-PM). , 2020, Blood.
[3] Cytopenia , 2020, Definitions.
[4] Daniel J. Devine,et al. Hybridization capture-based next generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid leukemia: a comparative study to standard fragment analysis , 2019, Modern Pathology.
[5] D. Steensma. Clinical Implications of Clonal Hematopoiesis , 2018, Mayo Clinic proceedings.
[6] M. Cazzola,et al. Clinical significance of somatic mutation in unexplained blood cytopenia. , 2017, Blood.
[7] R. Bejar. CHIP, ICUS, CCUS and other four-letter words , 2017, Leukemia.
[8] S. Barrans,et al. Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression. , 2015, Blood.
[9] J. Witte,et al. MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance. , 2015, Blood.
[10] B. Ebert,et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. , 2015, Blood.
[11] Joshua F. McMichael,et al. Age-related cancer mutations associated with clonal hematopoietic expansion , 2014, Nature Medicine.
[12] C. Franceschi,et al. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.
[13] B. Cheson,et al. Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. , 2006, Blood.